Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
OPKO Health Inc
OPK
Healthcare
Diagnostics & Research
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two...
antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers la...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:OPK)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(4)
•••
dragshot
X
Post by
dragshot
on Sep 19, 2025 9:12am
Bought some yesterday
Expecting a good result today and into the next week. GL
(155)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 07, 2025 2:27pm
Still holding this stock.Wow
It is in my portfolio for about a year and it has been a good one for me so far.Well,as of the today's market action,it is giving my portfolio big paper profits of more than $100,000 U.S.
How Smart Investors Are Positioning for the Next Innovation Cycle
posted May 13, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
Gain a sharper edge with data-backed insights into disruptive technologies, innovation trends, and evolving investor opportunities. Explore Episode 1 and discover what could define the next generation of market leaders. ...Learn More
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 01, 2024 7:50pm
OPKO Health, Inc. (NASDAQ:OPK): Diversified Healthcare Compa
https://beyondspx.com/2024/08/01/opko-health-inc-nasdaqopk-diversified-healthcare-company-streamlining-operations-and-advancing-promising-pipeline/
(155)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jul 19, 2024 10:45am
This pharmacist stock and biotech stock was
Bought by me at the beginning of this year.As usual for me,it was a boat load of shares :100000 shares at .90cents/share which was near its all time low of .85 cents per share and it's all time
...more
(59)
•••
Nibinator
X
Post by
Nibinator
on Mar 31, 2024 9:05pm
BUY BUY BUY BUY BUY
I starting the day with this ... high hopes sings frankie boy
(0)
•••
Irene89
X
Post by
Irene89
on Apr 13, 2023 3:38am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
Irene89
X
Post by
Irene89
on Jul 15, 2022 9:16pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
Irene89
X
Post by
Irene89
on Jun 03, 2022 4:56am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
Irene89
X
Post by
Irene89
on Jun 02, 2022 12:12am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
Irene89
X
Post by
Irene89
on May 11, 2022 1:21am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
Irene89
X
Post by
Irene89
on Apr 30, 2022 3:04am
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
Irene89
X
Post by
Irene89
on Apr 22, 2022 12:30am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
Irene89
X
Post by
Irene89
on Apr 16, 2022 3:32am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
Irene89
X
Post by
Irene89
on Apr 09, 2022 1:59am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
Irene89
X
Post by
Irene89
on Apr 07, 2022 12:06pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Podcasts